Sedacoron
Replacement
|
Medicines
|
03/07/2014
The marketing authorization holder informed its supplied customers by letter dated July 1, 2014, that the sedacoron batch DV6862 delivered in the period from February 2014 to May 2014 exhibited increased crystallization, so that a precautionary replacement will be carried out.
| Name of the medicinal product | Sedacoron 150 mg - Konzentrat zur Infusionsbereitung |
|---|---|
| Marketing authorisation number(s) | 1-18027 |
| Marketing authorisation holder | Ebewe Pharma GmbH Nfg KG |
| Batch number(s) | DV6862 |
| Classification of the recall | 2 |
| BASG reference number | INS - 640.001 - 1 092 |
Further inquiry note
Page last modified:
12/07/2022